from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0219/-

LFCtreatmentdescriptionclass of inhibitor

0.016

Amikacinug/mL Amikacintranslation

-0.030

Cap5-10ug/mL Capreomycintranslation

0.655

Rox10-50 ug/mL Roxithromycintranslation

-0.626

SM2-5 ug/mL Streptomycintranslation

1.160

Tet5-10 ug/mL Tetracyclinetranslation

0.655

Rif0.2-5ug/mL Rifampicintranscription

0.782

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.134

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.167

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.397

CPZ10-50 ug/mL Chlorpromazinerespiration

0.750

Clofazimine10-13 ug/mL Clofaziminerespiration

-1.058

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.199

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.230

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.926

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.570

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.337

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.303

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.722

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.532

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-0.237

Nigericin50 uM Nigericinrespiration

0.142

TRC10-150 ug/mL Triclosanrespiration

0.562

TRZ10-25 ug/mL Thioridazinerespiration

-0.627

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-1.088

menadione6-10 ug/mL Menadionerespiration

1.169

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.015

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.474

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.826

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.087

NRP_1Non-replicating persistence stage 1dosRassociated

0.311

Amp0.2mg/mL AmpicillincellWall

-0.296

Cephalexin20-100 ug/mL CephalexincellWall

0.866

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.310

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

1.027

EMB10-20 ug/mL EthambutolcellWall

-0.168

Eta12-40 ug/mL EthionamidecellWall

0.162

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.137

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.169

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.079

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.149

BZA0.12 mg/mL BenzamidearomaticAmides

0.079

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.103

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.094

H2O24 mM hydrogen peroxideDNAdamaging

0.358

Levo10 ug/mL LevofloxacinDNAdamaging

-0.345

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.101

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.010

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.070

UVUV-irradiationDNAdamaging

-0.986

ARP41-4 ug/mL Antitubercular compound ARP4?

0.372

Antimycin12.5-50 ug/mL Antimycin A?

-0.479

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.665

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.269

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.333

PA8240.2-2 ug/mL PA-824?

-0.384

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.091

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.071

Verapamil50 uM Verapamil?

-0.232

mercaptoethanol2 mM 2-Mercaptoethanol?

0.136

methoxatin10-20 ug/mL Methoxatin?